Physician profile
Bart D Putterman
NPI 1720140650
$4,844.34
in general payments reported to CMS, 2019-2025
38 companies · $571 in 2025
The $571 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $943 · 2020: $442 · 2021: $814 · 2022: $1,032 · 2023: $671 · 2024: $371 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,612.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $577.94 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $483.80 | 2019-2023 | |
| Exeltis, USA INC. | $428.28 | 2019-2024 | Slynd |
| Abbvie INC. | $403.15 | 2019-2022 | |
| Astellas Pharma US INC | $352.74 | 2022-2025 | Veozah |
| Caldera Medical, INC | $247.92 | 2022-2023 | Desara |
| Medtronic, INC. | $189.65 | 2022-2025 | Truclear |
| Mayne Pharma Commercial LLC | $178.55 | 2022-2024 | |
| Coopersurgical, INC. | $175.95 | 2019-2024 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $165.08 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $164.33 | 2019-2025 | Novasure, Fluent Fluid Management System, Aptima |
| Myovant Sciences INC. | $159.03 | 2021-2022 | |
| Sage Therapeutics, LLC | $151.35 | 2024-2025 | Zurzuvae |
| Avion Pharmaceuticals | $139.56 | 2019-2022 | |
| Organon LLC | $123.36 | 2021-2025 | Nexplanon |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $88.24 | 2019-2021 | |
| Lupin INC. | $81.14 | 2019-2021 | |
| Allergan, INC. | $80.12 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $78.01 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $68.34 | 2019-2021 | |
| Amgen INC. | $64.60 | 2019-2022 | |
| Millicent US INC | $58.76 | 2023-2025 | Femring, Intrarosa, Femlyv |
| Dexcom, INC. | $40.75 | 2025 | Dexcom G6 Transmitter |
| Evofem Biosciences, INC. | $38.00 | 2022 | |
| Gynesonics, INC. | $33.35 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Scynexis, INC. | $27.36 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $27.24 | 2025 | Exparel |
| Covidien Lp | $27.04 | 2019 | |
| Supernus Pharmaceuticals, INC. | $24.26 | 2025 | Qelbree |
| Minerva Surgical, INC | $23.26 | 2019 | |
| Convatec INC. | $23.11 | 2021 | |
| Integra Lifesciences Corporation | $22.96 | 2023 | Duraseal Exact Spinal Sealant System, Cusa Clarity, Codman Hakim |
| Optumhealth Care Solutions, LLC | $18.59 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Lilly USA, LLC | $17.67 | 2025 | Mounjaro |
| Cumberland Pharmaceuticals, INC. | $15.68 | 2024 | Caldolor |
| Exact Sciences Corporation | $15.34 | 2025 | Cologuard Collection Kit |
| Ethicon US, LLC | $15.29 | 2025 | Ethicon, Dermabond Prineo, Stratafix |
| Smith+Nephew, INC. | $14.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bart Putterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.